Key cellular enzyme could be effective drug target in urologic cancer cells

A key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney, new research indicates. Ongoing research into treatments for kidney cancer is especially important since kidney cancer is known to be resistant to current chemotherapy and radiation.

Read the whole article on Science Daily

More from Science Daily